Medical Device manufacturers are facing unprecedented change. With different regulatory definitions for devices and combination products, complex new technologies are blurring the line between pharmaceutical and medical device development, like novel drug-delivery systems, combination packs and personalized medicine. Together with apps for personalized health, total quality management like the FDA Case for Quality, pressure on costs and increasing market volatility drive the need to transform manufacturing operations across the Life Sciences industry. Medical device and diagnostic products are becoming increasingly complex. Combination products and next-generation products can therefore not be effectively manufactured in last-generation factories. The Life Sciences Factory of the Future moves beyond the factory walls, which requires digital transformation across the entire medical products value network.
No matter where your company is on its path to digital transformation, DELMIA helps companies throughout the Medical Device manufacturing supply chain to connect the virtual and real worlds of value networks to re-imagine operations for achieving excellence. Using DELMIA solutions, our world leading customers ensure product quality and eDHR compliance, synchronize material flows, accelerate NPI and support cost reductions and continuous improvement programs in a regulated environment.
Key Benefits:
Made to Cure for Medical Device Manufacturing
Significant pressure to lower costs and service more niche markets typically drive the next generation of manufacturing, but today, the voice of the patient is growing louder and patient preference must be embedded into the product design to be in full regulatory compliance. In order to meet these demands and the needs of people around the world, companies must be agile by instituting an adaptive, more flexible infrastructure.
